TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 51 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,660,000 | +4.7% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $12,095,000 | -1.0% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,214,000 | -0.8% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,314,000 | +2.1% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,056,000 | -3.5% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $12,491,000 | +0.9% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $12,380,000 | +5.7% | 13,285,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,710,000 | – | 13,285,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 122,602,000 | $157,856,000 | 6.24% |
| Lombard Odier Asset Management (Europe) Ltd | 53,907,000 | $69,236,000 | 4.40% |
| MACKAY SHIELDS LLC | 41,286,000 | $52,954,000 | 2.92% |
| Ferox Capital Management LP | 3,500,000 | $4,517,000 | 2.54% |
| INCOME RESEARCH & MANAGEMENT | 13,354,000 | $17,068,000 | 2.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,715,000 | $11,210,000 | 1.32% |
| Calamos Wealth Management LLC | 2,209,000 | $2,828,000 | 0.81% |
| Compagnie Lombard Odier SCmA | 5,050,000 | $6,515,000 | 0.26% |
| VICTORY CAPITAL MANAGEMENT INC | 17,957,869 | $22,954,000 | 0.16% |
| THRIVENT FINANCIAL FOR LUTHERANS | 16,500,000 | $21,172,000 | 0.12% |